InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by RAPP MICHAEL, Director. Officer active across 1 companies, notably Immunome Inc.. Aggregated, 6 filings have been published. Total volume traded: €2.1m. The latest transaction was filed on 13 September 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€438,70925,962 shares@ €16.898142.2% of flow
Common Stock
SEC:0001104659-21-115280·
Ideal exit: 10 Jun 2022 (T+270)
€438,70925,962 shares@ €16.89810.019% mcap21.1% of flow
Common Stock
SEC:0001104659-21-115280:0·
Ideal exit: 10 Jun 2022 (T+270)
€120,4858,170 shares@ €14.747311.6% of flow
Common Stock
SEC:0001104659-21-114881·
Ideal exit: 6 Jun 2022 (T+270)
€120,4858,170 shares@ €14.74730.0051% mcap5.8% of flow
Common Stock
SEC:0001104659-21-114881:0·
Ideal exit: 6 Jun 2022 (T+270)
€479,94131,895 shares@ €15.047546.2% of flow
Common Stock
SEC:0001104659-21-072620·
Ideal exit: 18 Feb 2022 (T+270)
€479,94131,895 shares@ €15.04750.020% mcap23.1% of flow
Common Stock
SEC:0001104659-21-072620:0·
Ideal exit: 18 Feb 2022 (T+270)
6 of 6 declarations
About RAPP MICHAEL
Michael Rapp is a Board Member at Immunome Inc. In this role, he contributes to overseeing the company's activities and making strategic decisions. Rapp brings his expertise in corporate governance and biotechnology, which is essential for guiding the organization's direction. His commitment to innovation and research is an asset to the board.
